Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Pietenpol · SciRah

Researcher profile · Semantic Scholar

J. Pietenpol

Share profile

J. Pietenpol — researcher profile on SciRah

h-index: 71
Works: 222
Citations: 29K

Most-cited papers

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.
B. Lehmann, J. Bauer, X. Chen, M. Sanders +3 more
2011Journal of Clinical Investigation5,078 citations Open access
Semantic Scholar
Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
B. Lehmann, B. Jovanovic, Xi Chen, M. V. Estrada +5 more
2016PLoS ONE1,291 citations Open access
Semantic Scholar
Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes
H. Masuda, K. Baggerly, Ying Wang, Ya Zhang +8 more
2013Clinical Cancer Research675 citations Open access
Semantic Scholar
Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets
J. Balko, J. Giltnane, Kai Wang, L. Schwarz +23 more
2013Cancer Discovery464 citations Open access
Semantic Scholar
Identification and use of biomarkers in treatment strategies for triple negative breast cancer subtypes
B. D. Lehmann, J. Pietenpol
2014Journal of Pathology435 citations Open access
Semantic Scholar
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors
B. Lehmann, J. Bauer, Johanna M. Schafer, Christopher S Pendleton +9 more
2014Breast Cancer Research322 citations Open access
Semantic Scholar
NEW STRATEGIES FOR TRIPLE NEGATIVE BREAST CANCER – DECIPHERING THE HETEROGENEITY
I. Mayer, V. Abramson, B. Lehmann, J. Pietenpol
2014Clinical Cancer Research283 citations Open access
Semantic Scholar
TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer
X. Chen, Jiang Li, William H. Gray, B. Lehmann +3 more
2012Cancer Informatics246 citations Open access
Semantic Scholar
Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes
B. Lehmann, A. Colaprico, T. Silva, Jian-Jiao Chen +11 more
2021Nature Communications238 citations Open access
Semantic Scholar
Identification of Markers of Taxane Sensitivity Using Proteomic and Genomic Analyses of Breast Tumors from Patients Receiving Neoadjuvant Paclitaxel and Radiation
J. Bauer, A. Chakravarthy, Jennifer M. Rosenbluth, D. Mi +15 more
2010Clinical Cancer Research175 citations Open access
Semantic Scholar
BRAF Fusions Define a Distinct Molecular Subset of Melanomas with Potential Sensitivity to MEK Inhibition
K. Hutchinson, D. Lipson, P. Stephens, G. Otto +9 more
2013Clinical Cancer Research173 citations Open access
Semantic Scholar
Triple-negative breast cancer: molecular subtypes and new targets for therapy.
B. Lehmann, J. Pietenpol, A. Tan
2015American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting149 citations
Semantic Scholar
p73 is Required for Multiciliogenesis and Regulates the Foxj1-Associated Gene Network
C. Marshall, D. Mays, J. Beeler, Jennifer M. Rosenbluth +9 more
2016Cell Reports143 citations Open access
Semantic Scholar
TBCRC 032 IB/II Multicenter Study: Molecular insights to AR antagonist and PI3K inhibitor efficacy in patients with AR+ metastatic triple-negative breast cancer
B. Lehmann, V. Abramson, M. Sanders, E. Mayer +14 more
2019Clinical Cancer Research125 citations Open access
Semantic Scholar
EGFR kinase domain duplication (EGFR-KDD) is a novel oncogenic driver in lung cancer that is clinically responsive to afatinib
Jean-Nicolas Gallant, Jonathan H. Sheehan, T. Shaver, M. Bailey +11 more
2015Cancer Discovery123 citations Open access
Semantic Scholar
Clinical implications of molecular heterogeneity in triple negative breast cancer
B. Lehmann, J. Pietenpol
2015Breast122 citations Open access
Semantic Scholar
Mislocalization of the cell polarity protein Scribble promotes mammary tumorigenesis and is associated with basal breast cancer
M. Feigin, S. D. Akshinthala, Kiyomi Y. Araki, Avi Z. Rosenberg +7 more
2014Cancer Research120 citations Open access
Semantic Scholar
A Synthetic Lethal Screen Identifies DNA Repair Pathways that Sensitize Cancer Cells to Combined ATR Inhibition and Cisplatin Treatments
K. Mohni, P. Thompson, Jessica W Luzwick, Gloria G. Glick +4 more
2015PLoS ONE104 citations Open access
Semantic Scholar
Patient-derived breast tumor xenografts facilitating personalized cancer therapy
M. Landis, B. Lehmann, J. Pietenpol, Jenny C. Chang
2013Breast Cancer Research93 citations Open access
Semantic Scholar
Multi-Perspective Quality Control of Illumina Exome Sequencing Data Using QC3
Yan Guo, Shi-Lin Zhao, Quan-Hu Sheng, Fei Ye +5 more
2014Genomics81 citations Open access
Semantic Scholar
Targeting mutant p53 in human tumors.
B. Lehmann, J. Pietenpol
2012Journal of Clinical Oncology74 citations
Semantic Scholar
Targeting MYCN-expressing triple-negative breast cancer with BET and MEK inhibitors
Johanna M. Schafer, B. Lehmann, P. González-Ericsson, C. Marshall +18 more
2020Science Translational Medicine64 citations Open access
Semantic Scholar
Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients
B. Ring, D. Hout, S. Morris, Kasey D. Lawrence +5 more
2016BMC Cancer64 citations Open access
Semantic Scholar
Novel p63 target genes involved in paracrine signaling and keratinocyte differentiation
Christopher E. Barton, Kimberly N. Johnson, D. M. Mays, K. Boehnke +3 more
2010Cell Death and Disease62 citations Open access
Semantic Scholar
Transforming growth factor beta receptor type III is a tumor promoter in mesenchymal-stem like triple negative breast cancer
B. Jovanovic, J. Beeler, Michael W. Pickup, A. Chytil +6 more
2014Breast Cancer Research56 citations Open access
Semantic Scholar
Comparative Study of Exome Copy Number Variation Estimation Tools Using Array Comparative Genomic Hybridization as Control
Yan Guo, Quanghu Sheng, David C. Samuels, B. Lehmann +3 more
2013BioMed Research International56 citations Open access
Semantic Scholar
NKG2A is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple Negative Breast Cancer
Brandie C. Taylor, Xiao-Peng Sun, P. González-Ericsson, V. Sanchez +16 more
2023Cancer Discovery55 citations Open access
Semantic Scholar
Development of a RSK Inhibitor as a Novel Therapy for Triple Negative Breast Cancer
Katarzyna A. Ludwik, J. Campbell, Mingzong Li, Y. Li +7 more
2016Molecular Cancer Therapeutics55 citations Open access
Semantic Scholar
RNAseq by Total RNA Library Identifies Additional RNAs Compared to Poly(A) RNA Library
Yan Guo, Shi-Lin Zhao, Quan-Hu Sheng, Ming-Rui Guo +4 more
2015BioMed Research International55 citations Open access
Semantic Scholar
Acquisition of aneuploidy drives mutant p53-associated gain-of-function phenotypes
Lindsay N Redman-Rivera, T. Shaver, Hai-Ling Jin, C. Marshall +7 more
2021Nature Communications46 citations Open access
Semantic Scholar
Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancer
A. Wilson, O. Fadare, A. Beeghly-Fadiel, D. Son +11 more
2015OncoTarget41 citations Open access
Semantic Scholar
Mitochondria sequence mapping strategies and practicability of mitochondria variant detection from exome and RNA sequencing data
Zhang-Xin Pan, David C. Samuels, B. Lehmann, T. Stricker +3 more
2016Briefings Bioinform.38 citations Open access
Semantic Scholar
p73 regulates ependymal planar cell polarity by modulating actin and microtubule cytoskeleton
S. Fuertes-Álvarez, Laura Maeso-Alonso, Javier Villoch-Fernández, Merit Wildung +9 more
2018Cell Death and Disease37 citations Open access
Semantic Scholar
Diverse, Biologically Relevant, and Targetable Gene Rearrangements in Triple-Negative Breast Cancer and Other Malignancies
T. Shaver, B. Lehmann, J. Beeler, Chung-I Li +5 more
2016Cancer Research37 citations Open access
Semantic Scholar
Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue
B. Jovanovic, Quan-Hu Sheng, R. Seitz, Kasey D. Lawrence +7 more
2017BMC Cancer34 citations Open access
Semantic Scholar
Racial/Ethnic Disparities in All-Cause Mortality Among Patients Diagnosed with Triple-Negative Breast Cancer
Fei Wang, Wei Zheng, C. Bailey, I. Mayer +2 more
2020Cancer Research31 citations Open access
Semantic Scholar
Design, Synthesis, and Biological Activity of Substrate Competitive SMYD2 Inhibitors.
S. Cowen, D. Russell, L. Dakin, Huawei Chen +13 more
2016Journal of Medicinal Chemistry28 citations Open access
Semantic Scholar
p73 regulates epidermal wound healing and induced keratinocyte programming
J. Beeler, C. Marshall, P. González-Ericsson, T. Shaver +7 more
2019PLoS ONE27 citations Open access
Semantic Scholar
Tissue-specific expression of p73 and p63 isoforms in human tissues
C. Marshall, J. Beeler, B. Lehmann, P. González-Ericsson +4 more
2021Cell Death and Disease26 citations Open access
Semantic Scholar
Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer
B. Lehmann, V. Abramson, E. Dees, P. Shah +13 more
2023JAMA Oncology25 citations Open access
Semantic Scholar
MYC Deregulation and PTEN Loss Model Tumor and Stromal Heterogeneity of Aggressive Triple-Negative Breast Cancer
Zinab O. Doha, Xiaoyan Wang, Nicholas L. Calistri, Jennifer R. Eng +25 more
2023Nature Communications24 citations Open access
Semantic Scholar
Differential regulation of the p73 cistrome by mammalian target of rapamycin reveals transcriptional programs of mesenchymal differentiation and tumorigenesis
Jennifer M. Rosenbluth, D. Mays, A. Jiang, Y. Shyr +1 more
2011Proceedings of the National Academy of Sciences of the United States of America24 citations Open access
Semantic Scholar
Differential pathologic complete response rates after neoadjuvant chemotherapy among molecular subtypes of triple-negative breast cancer.
H. Masuda, K. Baggerly, Ying Wang, Ya Zhang +8 more
201315 citations
Semantic Scholar
Identification of targetable recurrent MAP3K8 rearrangements in melanomas lacking known driver mutations
B. Lehmann, T. Shaver, Douglas B. Johnson, Zhu Li +5 more
2019Molecular Cancer Research13 citations Open access
Semantic Scholar
Detection of internal exon deletion with exon Del
Yan Guo, Shi-Lin Zhao, B. Lehmann, Quan-Hu Sheng +4 more
2014BMC Bioinformatics13 citations Open access
Semantic Scholar
Abstract PD1-6: A randomized phase II neoadjuvant study of cisplatin, paclitaxel with or without everolimus (an mTOR inhibitor) in patients with stage II/III triple-negative breast cancer (TNBC)
I. Mayer, B. Jovanovic, V. Abramson, E. Mayer +13 more
201313 citations
Semantic Scholar
Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer
Elizabeth C. Wescott, Xiao-Peng Sun, P. González-Ericsson, Ann Hanna +24 more
2024Cancer Research Communications10 citations Open access
Semantic Scholar
Susan G. Komen Big Data for Breast Cancer Initiative: How Patient Advocacy Organizations Can Facilitate Using Big Data to Improve Patient Outcomes
J. Jourquin, Stephanie Birkey Reffey, C. Jernigan, M. Levy +4 more
2019JCO Precision Oncology9 citations Open access
Semantic Scholar
Analysis of high-throughput RNAi screening data in identifying genes mediating sensitivity to chemotherapeutic drugs: statistical approaches and perspectives
Fei Ye, J. Bauer, J. Pietenpol, Y. Shyr
2012BMC Genomics8 citations Open access
Semantic Scholar
PD09-06: Phase II Trial of RAD001 (Everolimus), an mTOR Inhibitor, with Weekly Cisplatin and Paclitaxel in Patients with HER2−Negative Metastatic Breast Cancer (MBC).
I. Mayer, J. Means-Powell, V. Abramson, Y. Shyr +6 more
20116 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

B. Lehmann×34
Invite
B. Lehmann — researcher profile on SciRah
Y. Shyr×15
Invite
Y. Shyr — researcher profile on SciRah
M. Sanders×13
Invite
M. Sanders — researcher profile on SciRah
P. González-Ericsson×9
Invite
P. González-Ericsson — researcher profile on SciRah

×8

Invite

J. Bauer — researcher profile on SciRah

Invite

J. Balko — researcher profile on SciRah

Invite

T. Shaver — researcher profile on SciRah

Kimberly N. Johnson×6

Invite

Kimberly N. Johnson — researcher profile on SciRah

Invite

V. Sanchez — researcher profile on SciRah

Invite

V. Abramson — researcher profile on SciRah

Invite

C. Marshall — researcher profile on SciRah

Invite

J. Beeler — researcher profile on SciRah